Market-Moving News for July 10th
Market-Moving News for July 10th
VVPR: 119% | VivoPower Secures Amendment And Extension To $34M Shareholder Loan Financing Agreement Following Negotiations With Independent Directors Of AWN Holdings Limited
VVPR: 119% | vivopower與AWN Holdings Limited獨立董事進行談判後，成功獲得了3400萬美元股東貸款融資協議的修訂和延期。
VRPX: 84% | Virpax Announces Results For A Swine Model Pilot Study For Probudur, Virpax's Long-acting Liposomal Bupivacaine Formulation Injected At A Wound Site To Provide Both Immediate And Extended Pain Relief
VRPX: 84% | Virpax宣佈對豬模型試驗的結果，採用Probudur，即Virpax的長效脂質體布比卡因製劑注射於傷口處，可提供即刻和長效止痛緩解。
LGVN: 52% | Longeveron Announces U.S. FDA Grants Lomecel-B Regenerative Medicine Advanced Therapy (RMAT) Designation For Treatment Of Mild Alzheimer's Disease
LGVN: 52% | Longeveron宣佈，該公司的 Alzheimer病輕度治療藥物Lomecel-b已被美國FDA授予再生醫學先進療法(RMAT)認證。